Total Payments
$4,878
2024 Payments
$1,543
Companies
22
Transactions
221
Medicare Patients
259
Medicare Billing
$44,107
Payment Breakdown by Category
Food & Beverage$4,832 (99.0%)
Education$46.91 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,832 | 220 | 99.0% |
| Education | $46.91 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $895.44 | 40 | $0 (2024) |
| ABBVIE INC. | $712.76 | 62 | $0 (2024) |
| Alkermes, Inc. | $677.23 | 26 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $429.00 | 13 | $0 (2023) |
| Axsome Therapeutics, Inc. | $405.98 | 7 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $317.11 | 11 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $276.92 | 13 | $0 (2024) |
| ITI, Inc. | $255.14 | 8 | $0 (2023) |
| Lundbeck LLC | $145.89 | 9 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $139.77 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,543 | 75 | Teva Pharmaceuticals USA, Inc. ($521.47) |
| 2023 | $1,833 | 78 | ABBVIE INC. ($310.12) |
| 2022 | $1,094 | 51 | Neurocrine Biosciences, Inc. ($231.60) |
| 2021 | $408.97 | 17 | Alkermes, Inc. ($164.14) |
All Payment Transactions
221 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug), HETLIOZ | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $105.63 | General |
| Category: CNS | ||||||
| 12/09/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: CNS | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.52 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: PSYCHIATRY | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.93 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.62 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.54 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $35.41 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.45 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $107.22 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Neuropsychiatry | ||||||
| 10/15/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $4.77 | General |
| Category: Central Nervous System | ||||||
| 10/14/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $104.36 | General |
| 10/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.26 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $92.31 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/08/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: PSYCHIATRY | ||||||
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.81 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $98.74 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 69 | 238 | $24,802 | $14,391 |
| 2022 | 2 | 69 | 230 | $23,224 | $13,092 |
| 2021 | 2 | 70 | 143 | $15,285 | $9,635 |
| 2020 | 2 | 51 | 114 | $13,269 | $6,989 |
Total Patients
259
Total Services
725
Medicare Billing
$44,107
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 195 | $23,843 | $13,866 | 58.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 12 | 43 | $959.33 | $525.60 | 54.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 56 | 181 | $22,131 | $12,472 | 56.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 13 | 49 | $1,093 | $620.06 | 56.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 58 | 121 | $14,795 | $9,326 | 63.0% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 12 | 22 | $490.82 | $308.91 | 62.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 37 | 97 | $11,860 | $6,251 | 52.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 14 | 17 | $1,408 | $737.97 | 52.4% |
About Judy Chava
Judy Chava is a Psychiatric/Mental Health healthcare provider based in Canton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/30/2018. The National Provider Identifier (NPI) number assigned to this provider is 1629556949.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Judy Chava has received a total of $4,878 in payments from pharmaceutical and medical device companies, with $1,543 received in 2024. These payments were reported across 221 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($4,832).
As a Medicare-enrolled provider, Chava has provided services to 259 Medicare beneficiaries, totaling 725 services with total Medicare billing of $44,107. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatric/Mental Health
- Location Canton, OH
- Active Since 07/30/2018
- Last Updated 07/30/2021
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1629556949
Products in Payments
- VRAYLAR (Drug) $712.76
- ARISTADA (Drug) $417.49
- Auvelity (Drug) $405.98
- Austedo XR (Drug) $348.86
- INGREZZA (Drug) $317.11
- CAPLYTA (Drug) $301.86
- UZEDY (Drug) $271.31
- AUSTEDO (Drug) $230.73
- LYBALVI (Drug) $228.70
- ABILIFY MAINTENA (Drug) $224.58
- SPRAVATO (Drug) $204.16
- REXULTI (Drug) $168.81
- INVEGA SUSTENNA (Drug) $153.84
- JORNAY PM (Drug) $138.79
- QUVIVIQ (Drug) $113.64
- FANAPT (Drug) $111.11
- SECUADO (Drug) $62.50
- INVEGA (Drug) $60.85
- COBENFY (Drug) $35.41
- LATUDA (Drug) $34.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Canton
Mrs. Kristin Hiltner, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $6,750
Psychiatric/Mental Health $6,750
Michael Putinski, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $3,686
Psychiatric/Mental Health $3,686
Mrs. Sherin Thurman, Aprn-Cnp, APRN-CNP
Psychiatric/Mental Health — Payments: $3,674
Psychiatric/Mental Health $3,674
Jaimie Machado, Fnp-C, FNP-C
Psychiatric/Mental Health — Payments: $3,345
Psychiatric/Mental Health $3,345
Jane Onyao, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $3,276
Psychiatric/Mental Health $3,276
Mrs. Breanna Millsap, Rn, RN
Psychiatric/Mental Health — Payments: $2,697
Psychiatric/Mental Health $2,697